EFFECT OF INFLUENZA VACCINES ON SUBPOPULATIONS OF BLOOD DENDRITIC CELLS
- Authors: Chromova E.A.1, Akhmatova E.A.1, Skhodova S.A.1, Semochkin I.A.1, Khomenkov V.G.1, Akhmatova N.K.1, Kostinov M.P.1
-
Affiliations:
- Mechnikov Research Institute of Vaccines and Sera
- Issue: Vol 93, No 5 (2016)
- Pages: 23-28
- Section: ORIGINAL RESEARCHES
- Submitted: 10.04.2019
- Published: 28.10.2016
- URL: https://microbiol.crie.ru/jour/article/view/83
- DOI: https://doi.org/10.36233/0372-9311-2016-5-23-28
- ID: 83
Cite item
Full Text
Abstract
About the authors
E. A. Chromova
Mechnikov Research Institute of Vaccines and Sera
Author for correspondence.
Email: noemail@neicon.ru
Россия
E. A. Akhmatova
Mechnikov Research Institute of Vaccines and Sera
Email: noemail@neicon.ru
Россия
S. A. Skhodova
Mechnikov Research Institute of Vaccines and Sera
Email: noemail@neicon.ru
Россия
I. A. Semochkin
Mechnikov Research Institute of Vaccines and Sera
Email: noemail@neicon.ru
Россия
V. G. Khomenkov
Mechnikov Research Institute of Vaccines and Sera
Email: noemail@neicon.ru
Россия
N. K. Akhmatova
Mechnikov Research Institute of Vaccines and Sera
Email: noemail@neicon.ru
Россия
M. P. Kostinov
Mechnikov Research Institute of Vaccines and Sera
Email: noemail@neicon.ru
Россия
References
- Bergmann-Leitner E.S., Leitner W.W., Tsokos G.C. Complement 3d: from molecular adjuvant to target of immune escape mechanisms. Clin. Immunol. 2006, Nov; 121 (2): 177-185.
- Duraisingham S.S., Rouphael N., Cavanagh M.M. et al. Systems biology of vaccination in the elderly. Curr. Top. Microbiol. Immunol. 2013, 363: 117-142.
- Geginat J., Nizzoli G., Paroni M. et al. Immunity to pathogens taught by specialized human dendritic cell subsets. Front. Immunol. 2015, Oct 13; 6: 527.
- Iwasaki A., Medzhitov R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 2015, Apr; 16 (4): 343-353.
- Kang I., Hong M.S., Nolasco H. et al. Age-associated change in the frequency of memory CD4+ T cells impairs longterm CD4+ T cell responses to influenza vaccine. J. Immunol. 2004, 173:673-681.
- Martins K.A., Bavari S., Salazar A.M. Vaccine adjuvant uses of poly-IC and derivatives. Expert. Rev. Vaccines. 2015, Mar; 14 (3): 447-459.
- Moyer T.J., Zmolek A.C., Irvine D.J. Beyond antigens and adjuvants: formulating future vaccines. J. Clin. Invest. 2016, Mar 1; 126 (3): 799-808.
- Sasaki S., Sullivan M., Narvaez C.F. et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest. 2011, 121: 3109-3119.
- Schenten D., Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 2011, 109: 87-124.
- Schettinil J., Mukheijee P. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clin. Dev. Immunol. 2008;2008:106321. doi: 10.1155/2008/106321. ll.Schijns V. Immunological concepts of vaccine adjuvant activity. Commentary. Curr. Op. Immunol. 2000, 12: 456-463.
- Trumpfheller C., Longhi M.P., Caskey M. et al. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity. J. Intern. Med. 2012, Feb; 271 (2): 183-192.
- Wagar L.E., Gentleman B., Pircher H. et alflnfluenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response. PLoS ONE. 2011, 6: e23698.
- Wang C., Liu R, Zhuang Y. et al. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory. Vaccine. 2014, Sep 22; 32 (42): 5475-5483.
- Yoo S., Ha S.J. Generation of tolerogenic dendritic cells and their therapeutic applications. Immune Netw. 2016, Feb; 16 (1): 52-60.